Savvy Advisors Inc. lifted its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 28.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,319 shares of the company’s stock after buying an additional 735 shares during the period. Savvy Advisors Inc.’s holdings in Colgate-Palmolive were worth $345,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of the company. Main Street Research LLC boosted its position in Colgate-Palmolive by 1.5% during the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after purchasing an additional 100 shares during the last quarter. Advisor OS LLC raised its holdings in shares of Colgate-Palmolive by 4.5% in the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock valued at $228,000 after purchasing an additional 101 shares during the period. BLB&B Advisors LLC increased its position in Colgate-Palmolive by 2.5% during the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock worth $421,000 after buying an additional 104 shares during the last quarter. ZWJ Investment Counsel Inc. raised its stake in Colgate-Palmolive by 3.1% in the second quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock valued at $349,000 after buying an additional 109 shares during the period. Finally, Hexagon Capital Partners LLC lifted its position in shares of Colgate-Palmolive by 9.5% in the second quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock valued at $124,000 after buying an additional 110 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Trading Down 0.5 %
Shares of CL stock opened at $91.51 on Wednesday. Colgate-Palmolive has a 1 year low of $75.17 and a 1 year high of $109.30. The company’s fifty day simple moving average is $100.62 and its two-hundred day simple moving average is $98.52. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock has a market capitalization of $74.76 billion, a price-to-earnings ratio of 26.22, a PEG ratio of 3.31 and a beta of 0.42.
Colgate-Palmolive Dividend Announcement
Wall Street Analysts Forecast Growth
CL has been the subject of several research analyst reports. Jefferies Financial Group downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their target price for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. UBS Group upped their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Barclays raised their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Finally, TD Cowen cut their price target on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $105.11.
View Our Latest Research Report on Colgate-Palmolive
Insider Buying and Selling
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Dividend Capture Strategy: What You Need to Know
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- How to Read Stock Charts for Beginners
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- 3 Monster Growth Stocks to Buy Now
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.